Spero Therapeutics (SPRO) Scheduled to Post Earnings on Thursday

Spero Therapeutics (NASDAQ:SPRO – Get Rating) will post its quarterly earnings results after the market closes on Thursday, March 31st. Analysts expect Spero Therapeutics to post earnings of ($0.81) per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link. Shares of Spero Therapeutics stock […]

Related Keywords

Ankit Mahadevia ,Wells Fargo Company ,Zacks Investment Research ,Spero Therapeutics Company Profile Get Rating ,Spero Therapeutics Inc ,Aquilo Capital Management Llc ,Citigroup Inc ,Barclays Plc ,Spero Therapeutics ,Get Rating ,Investment Research ,Aquilo Capital Management ,Therapeutics Company Profile ,Nasdaq Spro ,Aspro ,Medical ,Earnings ,